Description:
Kalorama Information presents an in-depth analysis of the in vitro diagnostic (IVD) market in Latin America, focusing on the significant countries and regions (including Argentina, Brazil, Chile, Colombia, Mexico, Peru, Venezuela and other nations) within this vast and diverse market. This essential report offers detailed insights into the market for reagents and instruments, providing a clear understanding of growth opportunities and trends in the region.
Overview
The IVD market in Latin America represents a substantial potential audience with a population of 646 million. Brazil and Mexico, accounting for over half of the region’s population, are primary focuses for IVD suppliers. However, as economic conditions improve, countries like Chile, Colombia, and Peru are emerging as key markets, offering additional opportunities for growth.
Market Trends and Insights
- Market Size and Growth: Detailed market size estimates and growth forecasts up to 2028.
- Geographic and Segment Analysis: In-depth analysis of key markets and segments, including reagents, consumables, calibrators, and controls.
- Competitive Landscape: Profiles of major companies, market share data, and competitive analysis.
- Regulatory Environment: Examination of regulations and their impact on the market.
Key Market Segments
This report meticulously analyzes various segments within the IVD market, including:
- Clinical Chemistry: Substrates, enzymes, homogeneous immunoassays, proteins, ISE (non-POC), HBA1c (non-POC).
- Critical Care: Blood gas and electrolytes, including rapid tests.
- Urinalysis: Manual, semi-automated, and automated systems, including urine strips and sediment reagents.
- Microbiology Immunoassays: HIV, Hepatitis, ToRCH, COVID-19, Influenza, Syphilis, and other infectious diseases.
- Non-Microbiology Immunoassay: Hormones, tumor markers, oncology markers, autoimmune tests, allergy, anemia, neonatal tests, and more.
- Cardiac Markers: Non-POC cardiac markers such as Troponin, BNP, CK-MB, Homocysteine, Myoglobin.
- Blood Banking: Immunotyping and infectious diseases screening.
- Microbiology: Manual and automated tests, culture media, latex tests, and more.
- Molecular Microbiology: HIV, Hepatitis, STDs, MRSA, MTB, Sepsis, and other infectious diseases.
- POC Testing: Allergy, autoimmune, cardiology, coagulation, and various other tests excluding glucose.
- POC Infectious Disease Testing: COVID-19, HIV, influenza, STDs, and other infectious diseases.
- POC Glucose Testing: Diabetes glucose monitoring strips.
- Histology: Primary and advanced staining, including IHC, ISH, and FISH.
- Hematology: Manual, semi-automated, and automated (CBC and 5 Diff).
- Coagulation: PT, APTT, coagulation factors, and other analytes from thrombosis and hemostasis pathways.
- Flow Cytometry: CD4/CD8 (AIDS), leukemia, lymphoma, and more.
- Other Molecular Testing: Hemato-oncology, hereditary diseases, transplant-related testing, and more.
For further details and to purchase directly, please contact us.
Sample Report: A sample is available as a PDF upon request.
Table: IVD in Latin America, 2022-2027 ($US thousands)
| Country | 2022 | 2027 | CAGR 2022-2027 |
| Argentina | $XX Thousands | $XX Thousands | XX% |
| Brazil | $XX Thousands | $XX Thousands | XX% |
| Chile | $XX Thousands | $XX Thousands | XX% |
| Colombia | $XX Thousands | $XX Thousands | XX% |
| Mexico | $XX Thousands | $XX Thousands | XX% |
| Peru | $XX Thousands | $XX Thousands | XX% |
| Venezuela | $XX Thousands | $XX Thousands | XX% |
| Other LATAM | $XX Thousands | $XX Thousands | XX% |
| Total LATAM | $XX Thousands | $XX Thousands | XX% |
Source: Kalorama Information
